Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus
- PMID: 32986906
- PMCID: PMC8088999
- DOI: 10.1111/jdi.13417
Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus
Abstract
Aims/introduction: Glucosuria is a representative symptom in diabetes patients with poor glycemic control and in those treated with sodium-glucose cotransporter 2 inhibitors. Renal threshold levels of glucose excretion are known to vary among individuals, but factors contributing to glucosuria are not well characterized. The present study aimed to clarify clinical and genetic determinants of glucosuria in individuals with diabetes mellitus.
Materials and methods: The 24-h urinary glucose excretion was measured in 135 hospitalized patients on admission, with continuous measurement for five consecutive days in 75 patients. Genetic and clinical factors contributing to glucosuria were studied. As a genetic factor, SLC5A2 polymorphism was genotyped. A total of 476 participants (266 participants with type 2 diabetes and 210 healthy controls) were additionally genotyped for the association study of SLC5A2 with type 2 diabetes. A meta-analysis was carried out with the present study and previous association studies.
Results: Multiple regression analysis showed that the independent variables of average blood glucose (β = 0.41, P = 1.4 × 10-7 ), estimated glomerular filtration rate (β = 0.28, P = 6.0 × 10-5 ), sex (β = 0.28, P = 5.7 × 10-5 ) and SLC5A2 rs9934336 polymorphism (β = 0.17, P = 0.02) were significantly correlated with urinary glucose excretion. The frequency of the A allele of rs9934336 tended to be lower in participants with type 2 diabetes than in controls (odds ratio 0.78, 95% confidence interval 0.53-1.13, not significant), and meta-analysis showed a significant association between the A allele and type 2 diabetes (summary odds ratio for minor allele [A] 0.86, 95% confidence interval 0.78-0.94, P < 0.002).
Conclusions: Blood glucose, estimated glomerular filtration rate, sex and SLC5A2 polymorphism were independent determinants of glucosuria in diabetes mellitus.
Keywords: SLC5A2; Diabetes mellitus; Glucosuria.
© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response.Mol Biol Rep. 2023 Nov;50(11):9637-9647. doi: 10.1007/s11033-023-08836-0. Epub 2023 Oct 11. Mol Biol Rep. 2023. PMID: 37819499 Review.
-
Clinical and Genetic Features of Patients With Type 2 Diabetes and Renal Glycosuria.J Clin Endocrinol Metab. 2017 May 1;102(5):1548-1556. doi: 10.1210/jc.2016-2332. J Clin Endocrinol Metab. 2017. PMID: 28324025
-
Are SGLT2 polymorphisms linked to diabetes mellitus and cardiovascular disease? Prospective study and meta-analysis.Biosci Rep. 2019 Aug 7;39(8):BSR20190299. doi: 10.1042/BSR20190299. Print 2019 Aug 30. Biosci Rep. 2019. PMID: 30988077 Free PMC article.
-
Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.Diabetes Care. 2017 Jun;40(6):771-776. doi: 10.2337/dc16-2724. Epub 2017 Mar 21. Diabetes Care. 2017. PMID: 28325783
-
SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes?Pharmacogenomics. 2013 May;14(7):825-33. doi: 10.2217/pgs.13.61. Pharmacogenomics. 2013. PMID: 23651029 Review.
Cited by
-
Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice.Front Endocrinol (Lausanne). 2025 Jul 7;16:1547920. doi: 10.3389/fendo.2025.1547920. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40692597 Free PMC article.
-
Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitorsinhibitor response.Mol Biol Rep. 2023 Nov;50(11):9637-9647. doi: 10.1007/s11033-023-08836-0. Epub 2023 Oct 11. Mol Biol Rep. 2023. PMID: 37819499 Review.
-
The Development and Validation of a Nomogram for Predicting Sepsis Risk in Diabetic Patients with Urinary Tract Infection.Medicina (Kaunas). 2025 Jan 27;61(2):225. doi: 10.3390/medicina61020225. Medicina (Kaunas). 2025. PMID: 40005342 Free PMC article.
-
Search for a Functional Genetic Variant Mimicking the Effect of SGLT2 Inhibitor Treatment.Genes (Basel). 2021 Jul 29;12(8):1174. doi: 10.3390/genes12081174. Genes (Basel). 2021. PMID: 34440348 Free PMC article.
References
-
- Gerich JE, Meyer C, Woerle HJ, et al. Renal gluconeogenesis: Its importance in human glucose homeostasis. Diabetes Care 2001; 24: 382–391. - PubMed
-
- Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium‐(potassium)‐chloride cotransporter family expressed in kidney. J Biol Chem 1994; 269: 17713–17722. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 17K09852/Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 18K08493/Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 18K08530/Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
LinkOut - more resources
Full Text Sources
Medical
Research Materials